These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6406952)

  • 21. Prevention of Rh sensitization. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1971; 468():3-36. PubMed ID: 4999558
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serology and prophylaxis of Rhesus-caused hemolytic disease of the newborn].
    Maresch W
    Wien Med Wochenschr; 1966 Nov; 116(46):972-4. PubMed ID: 4966249
    [No Abstract]   [Full Text] [Related]  

  • 23. Prevention of rhesus haemolytic disease in Finland.
    Eklund J
    Haematologia (Budap); 1982 Dec; 15(4):423-6. PubMed ID: 6821166
    [No Abstract]   [Full Text] [Related]  

  • 24. [Novel treatments of Rh-immunization].
    Ulander VM; Halmesmäki E; Ammälä P
    Duodecim; 2004; 120(24):2897-904. PubMed ID: 15700584
    [No Abstract]   [Full Text] [Related]  

  • 25. [The danger of sensitization by miscarriages].
    Krebs D
    Bibl Haematol; 1969; 32():141-3. PubMed ID: 4980800
    [No Abstract]   [Full Text] [Related]  

  • 26. [Severe erythroblastosis fetalis due to c-antigen incompatibility].
    Abody Z; Alon U; Sujov P; Zeltzer M
    Harefuah; 1979 Jun; 96(12):655-6. PubMed ID: 118085
    [No Abstract]   [Full Text] [Related]  

  • 27. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 28. [Rh incompatability from the viewpoint of the pediatrician].
    Stur O
    Wien Klin Wochenschr; 1970 May; 82(20):369-71. PubMed ID: 5002768
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of hemolytic disease in newborns caused by antiagglutinins E (RH)].
    Argirov A; Mikhova M
    Vopr Okhr Materin Det; 1968 Oct; 13(10):71-2. PubMed ID: 4976398
    [No Abstract]   [Full Text] [Related]  

  • 30. Reduction of Rh (D) sensitization: a cost-effective analysis.
    Hensleigh PA
    Obstet Gynecol; 1983 Apr; 61(4):537-8. PubMed ID: 6402742
    [No Abstract]   [Full Text] [Related]  

  • 31. [Histological peculiarities of the placenta in materno-fetal isoimmunization due to Rh factors].
    Capone N; Urbanetti S; Sobrino R; Sobrino S
    Minerva Ginecol; 1982 Mar; 34(3):151-4. PubMed ID: 6806722
    [No Abstract]   [Full Text] [Related]  

  • 32. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 35. [Rh alloimmunization].
    Boda D; Pataki L
    Orv Hetil; 1996 Nov; 137(44):2485. PubMed ID: 9026764
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence of Rh immunization in primigravidae and risk of immunization in multiparae.
    Lundsgaard A
    Ann Ostet Ginecol Med Perinat; 1970 Jul; 92(7):450-1. PubMed ID: 5003524
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of hemolytic disease of the newborn caused by materno-fetal isoimmunization against factor c(hr') (preliminary note)].
    De Luca P
    Arch Ostet Ginecol; 1980; 85(3):175-7. PubMed ID: 6802114
    [No Abstract]   [Full Text] [Related]  

  • 39. [Newborn infants of mothers with suspected potential diabetes, showing erythroblastosis fetalis due to feto-maternal incompatibility].
    Hoet JJ
    Diabete; 1967; 15(1):36-40. PubMed ID: 4963081
    [No Abstract]   [Full Text] [Related]  

  • 40. Reduction of Rh0(D) sensitization: a cost-effective analysis.
    Lim OW; Fleisher AA; Ziel HK
    Obstet Gynecol; 1982 Apr; 59(4):477-80. PubMed ID: 6176925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.